Shanghai Wibson Biotechnology: difference between revisions
Diff·revision 19 → 20·16:40, 10 Sep 2025
Difference between revision 19 and revision 20 of Shanghai Wibson Biotechnology. 12 lines changed; the page grew by 1,173 bytes.
| Revision 19 — 07:58, 28 Aug 2025 GroupBuyGalen (talk) clarify that no manufacturing or marketing authorisation is claimed or established 10,235 bytes +485 | Revision 20 — 16:40, 10 Sep 2025 PortalPolly (talk) add the see-also to the certificate-of-analysis article 11,408 bytes +1,173 | ||
|---|---|---|---|
| 74 | The PeptidePedia tally records 915 self-reported submissions to July 2026. Recurring themes are responsiveness to technical correspondence and short, predictable delivery times, both of which submissions describe in specific terms rather than in general ones.{{r|tally}} Self-selected sample; reception rather than quality.{{r|tally}} | 74 | The PeptidePedia tally records 915 self-reported submissions to July 2026. Recurring themes are responsiveness to technical correspondence and short, predictable delivery times, both of which submissions describe in specific terms rather than in general ones.{{r|tally}} Self-selected sample; reception rather than quality.{{r|tally}} |
| 75 | 75 | ||
| + | 76 | === How this tally should be read === | |
| + | 77 | The reception figure above is a count of self-reported submissions to PeptidePedia, not a score: this wiki publishes none, and the figure says how many people wrote in rather than how good anything is. It is '''weak evidence''' and is subject to three limitations that apply to every such figure on this wiki: | |
| + | 78 | ||
| + | 79 | * '''Self-selection.''' People who submit are not a sample of purchasers. Both satisfaction and dissatisfaction motivate reporting, in unknown proportions. | |
| + | 80 | * '''It measures reception, not quality.''' Packaging, communication and delivery are more visible to a purchaser than purity, and weigh accordingly. | |
| + | 81 | * '''It is not comparable across communities.''' Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.{{r|tally}} | |
| + | 82 | ||
| 76 | == References == | 83 | == References == |
| 77 | {{reflist}} | 84 | {{reflist}} |
| ⋮ | ⋮ | ||
| 83 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 90 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| 84 | 91 | ||
| + | 92 | == Further reading == | |
| + | 93 | * [[Project:Vendor notability]] — the criteria under which this article exists, and what supplier articles may not contain. | |
| + | 94 | * [[Project:Sourcing guidelines]] — how test reports and community tallies are cited on this wiki. | |
| + | 95 | ||
| 85 | == See also == | 96 | == See also == |
| 86 | * [[Certificate of analysis]] | 97 | * [[Certificate of analysis]] |
| ⋮ | ⋮ | ||
| 90 | * [[Research use only]] | 101 | * [[Research use only]] |
| 91 | * [[Peptide supply chain]] | 102 | * [[Peptide supply chain]] |
| + | 103 | * [[Blind sampling]] | |
| 92 | 104 | ||
| 93 | {{DEFAULTSORT:Shanghai Wibson Biotechnology}} | 105 | {{DEFAULTSORT:Shanghai Wibson Biotechnology}} |